BGLC Stock Summary and Trading Ideas (Bionexus Gene Lab | NASDAQ:BGLC)

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Bionexus Gene Lab trades on the NASDAQ stock market under the symbol BGLC.

As of June 9, 2026, BGLC stock price declined to $2.17 with 6,615 million shares trading.

BGLC has a beta of 0.55, meaning it tends to be less sensitive to market movements. BGLC has a correlation of 0.00 to the broad based SPY ETF.

BGLC has a market cap of $5.26 million. This is considered a Sub-Micro Cap stock.

BGLC has underperformed the market in the last year with a return of -29.8%, while the SPY ETF gained +24.3%. In the last 3 month period, BGLC fell short of the market, returning -13.0%, while SPY returned +9.9%. However, in the most recent 2 weeks BGLC has outperformed the stock market by returning +7.9%, while SPY returned -1.2%.

BGLC support price is $2.08 and resistance is $2.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BGLC shares will trade within this expected range on the day.